Global Covid-19 Rapid Antigen Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Covid-19 Rapid Antigen market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Covid-19 Rapid Antigen market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Covid-19 Rapid Antigen market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Covid-19 Rapid Antigen market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Covid-19 Rapid Antigen market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Covid-19 Rapid Antigen market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Covid-19 Rapid Antigen
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Covid-19 Rapid Antigen market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Access Bio, BD, Quidel and Fujirebio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Covid-19 Rapid Antigen market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Covid-19 Rapid Antigen product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Covid-19 Rapid Antigen, with price, sales, revenue and global market share of Covid-19 Rapid Antigen from 2018 to 2023.
Chapter 3, the Covid-19 Rapid Antigen competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Covid-19 Rapid Antigen breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Covid-19 Rapid Antigen market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Covid-19 Rapid Antigen.
Chapter 14 and 15, to describe Covid-19 Rapid Antigen sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Covid-19 Rapid Antigen market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Covid-19 Rapid Antigen market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Covid-19 Rapid Antigen market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Covid-19 Rapid Antigen market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Covid-19 Rapid Antigen market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Covid-19 Rapid Antigen
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Covid-19 Rapid Antigen market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Access Bio, BD, Quidel and Fujirebio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Covid-19 Rapid Antigen market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Nasal Swab
- Oral Fluid/Saliva
- Hospitals
- Scientific Research
- Abbott
- Access Bio
- BD
- Quidel
- Fujirebio
- Ellume
- OraSure Technologies
- Clip Health
- Celltrion Healthcare
- Salofa Oy
- iHealth Labs
- Novegent
- Hangzhou Alltest Biotech
- Guangzhou Decheng Biotechnology
- SD Biosensor
- MP Biomedical
- Jiangsu Well Biotech
- CTK Biotech
- Hangzhou Laihe Biotech
- Innovation Scientific
- Biohit Healthcare
- ACON Biotech
- Assure Tech
- Hangzhou Clongene Biotech
- Hangzhou Testsea Biotechnology
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Covid-19 Rapid Antigen product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Covid-19 Rapid Antigen, with price, sales, revenue and global market share of Covid-19 Rapid Antigen from 2018 to 2023.
Chapter 3, the Covid-19 Rapid Antigen competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Covid-19 Rapid Antigen breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Covid-19 Rapid Antigen market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Covid-19 Rapid Antigen.
Chapter 14 and 15, to describe Covid-19 Rapid Antigen sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Covid-19 Rapid Antigen
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Covid-19 Rapid Antigen Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Nasal Swab
1.3.3 Oral Fluid/Saliva
1.4 Market Analysis by Application
1.4.1 Overview: Global Covid-19 Rapid Antigen Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Scientific Research
1.5 Global Covid-19 Rapid Antigen Market Size & Forecast
1.5.1 Global Covid-19 Rapid Antigen Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Covid-19 Rapid Antigen Sales Quantity (2018-2029)
1.5.3 Global Covid-19 Rapid Antigen Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Covid-19 Rapid Antigen Product and Services
2.1.4 Abbott Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Recent Developments/Updates
2.2 Access Bio
2.2.1 Access Bio Details
2.2.2 Access Bio Major Business
2.2.3 Access Bio Covid-19 Rapid Antigen Product and Services
2.2.4 Access Bio Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Access Bio Recent Developments/Updates
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business
2.3.3 BD Covid-19 Rapid Antigen Product and Services
2.3.4 BD Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BD Recent Developments/Updates
2.4 Quidel
2.4.1 Quidel Details
2.4.2 Quidel Major Business
2.4.3 Quidel Covid-19 Rapid Antigen Product and Services
2.4.4 Quidel Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Quidel Recent Developments/Updates
2.5 Fujirebio
2.5.1 Fujirebio Details
2.5.2 Fujirebio Major Business
2.5.3 Fujirebio Covid-19 Rapid Antigen Product and Services
2.5.4 Fujirebio Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Fujirebio Recent Developments/Updates
2.6 Ellume
2.6.1 Ellume Details
2.6.2 Ellume Major Business
2.6.3 Ellume Covid-19 Rapid Antigen Product and Services
2.6.4 Ellume Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Ellume Recent Developments/Updates
2.7 OraSure Technologies
2.7.1 OraSure Technologies Details
2.7.2 OraSure Technologies Major Business
2.7.3 OraSure Technologies Covid-19 Rapid Antigen Product and Services
2.7.4 OraSure Technologies Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 OraSure Technologies Recent Developments/Updates
2.8 Clip Health
2.8.1 Clip Health Details
2.8.2 Clip Health Major Business
2.8.3 Clip Health Covid-19 Rapid Antigen Product and Services
2.8.4 Clip Health Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Clip Health Recent Developments/Updates
2.9 Celltrion Healthcare
2.9.1 Celltrion Healthcare Details
2.9.2 Celltrion Healthcare Major Business
2.9.3 Celltrion Healthcare Covid-19 Rapid Antigen Product and Services
2.9.4 Celltrion Healthcare Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Celltrion Healthcare Recent Developments/Updates
2.10 Salofa Oy
2.10.1 Salofa Oy Details
2.10.2 Salofa Oy Major Business
2.10.3 Salofa Oy Covid-19 Rapid Antigen Product and Services
2.10.4 Salofa Oy Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Salofa Oy Recent Developments/Updates
2.11 iHealth Labs
2.11.1 iHealth Labs Details
2.11.2 iHealth Labs Major Business
2.11.3 iHealth Labs Covid-19 Rapid Antigen Product and Services
2.11.4 iHealth Labs Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 iHealth Labs Recent Developments/Updates
2.12 Novegent
2.12.1 Novegent Details
2.12.2 Novegent Major Business
2.12.3 Novegent Covid-19 Rapid Antigen Product and Services
2.12.4 Novegent Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Novegent Recent Developments/Updates
2.13 Hangzhou Alltest Biotech
2.13.1 Hangzhou Alltest Biotech Details
2.13.2 Hangzhou Alltest Biotech Major Business
2.13.3 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product and Services
2.13.4 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hangzhou Alltest Biotech Recent Developments/Updates
2.14 Guangzhou Decheng Biotechnology
2.14.1 Guangzhou Decheng Biotechnology Details
2.14.2 Guangzhou Decheng Biotechnology Major Business
2.14.3 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product and Services
2.14.4 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Guangzhou Decheng Biotechnology Recent Developments/Updates
2.15 SD Biosensor
2.15.1 SD Biosensor Details
2.15.2 SD Biosensor Major Business
2.15.3 SD Biosensor Covid-19 Rapid Antigen Product and Services
2.15.4 SD Biosensor Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 SD Biosensor Recent Developments/Updates
2.16 MP Biomedical
2.16.1 MP Biomedical Details
2.16.2 MP Biomedical Major Business
2.16.3 MP Biomedical Covid-19 Rapid Antigen Product and Services
2.16.4 MP Biomedical Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 MP Biomedical Recent Developments/Updates
2.17 Jiangsu Well Biotech
2.17.1 Jiangsu Well Biotech Details
2.17.2 Jiangsu Well Biotech Major Business
2.17.3 Jiangsu Well Biotech Covid-19 Rapid Antigen Product and Services
2.17.4 Jiangsu Well Biotech Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Jiangsu Well Biotech Recent Developments/Updates
2.18 CTK Biotech
2.18.1 CTK Biotech Details
2.18.2 CTK Biotech Major Business
2.18.3 CTK Biotech Covid-19 Rapid Antigen Product and Services
2.18.4 CTK Biotech Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 CTK Biotech Recent Developments/Updates
2.19 Hangzhou Laihe Biotech
2.19.1 Hangzhou Laihe Biotech Details
2.19.2 Hangzhou Laihe Biotech Major Business
2.19.3 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product and Services
2.19.4 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Hangzhou Laihe Biotech Recent Developments/Updates
2.20 Innovation Scientific
2.20.1 Innovation Scientific Details
2.20.2 Innovation Scientific Major Business
2.20.3 Innovation Scientific Covid-19 Rapid Antigen Product and Services
2.20.4 Innovation Scientific Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Innovation Scientific Recent Developments/Updates
2.21 Biohit Healthcare
2.21.1 Biohit Healthcare Details
2.21.2 Biohit Healthcare Major Business
2.21.3 Biohit Healthcare Covid-19 Rapid Antigen Product and Services
2.21.4 Biohit Healthcare Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Biohit Healthcare Recent Developments/Updates
2.22 ACON Biotech
2.22.1 ACON Biotech Details
2.22.2 ACON Biotech Major Business
2.22.3 ACON Biotech Covid-19 Rapid Antigen Product and Services
2.22.4 ACON Biotech Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 ACON Biotech Recent Developments/Updates
2.23 Assure Tech
2.23.1 Assure Tech Details
2.23.2 Assure Tech Major Business
2.23.3 Assure Tech Covid-19 Rapid Antigen Product and Services
2.23.4 Assure Tech Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Assure Tech Recent Developments/Updates
2.24 Hangzhou Clongene Biotech
2.24.1 Hangzhou Clongene Biotech Details
2.24.2 Hangzhou Clongene Biotech Major Business
2.24.3 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product and Services
2.24.4 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 Hangzhou Clongene Biotech Recent Developments/Updates
2.25 Hangzhou Testsea Biotechnology
2.25.1 Hangzhou Testsea Biotechnology Details
2.25.2 Hangzhou Testsea Biotechnology Major Business
2.25.3 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product and Services
2.25.4 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Hangzhou Testsea Biotechnology Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: COVID-19 RAPID ANTIGEN BY MANUFACTURER
3.1 Global Covid-19 Rapid Antigen Sales Quantity by Manufacturer (2018-2023)
3.2 Global Covid-19 Rapid Antigen Revenue by Manufacturer (2018-2023)
3.3 Global Covid-19 Rapid Antigen Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Covid-19 Rapid Antigen by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Covid-19 Rapid Antigen Manufacturer Market Share in 2022
3.4.2 Top 6 Covid-19 Rapid Antigen Manufacturer Market Share in 2022
3.5 Covid-19 Rapid Antigen Market: Overall Company Footprint Analysis
3.5.1 Covid-19 Rapid Antigen Market: Region Footprint
3.5.2 Covid-19 Rapid Antigen Market: Company Product Type Footprint
3.5.3 Covid-19 Rapid Antigen Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Covid-19 Rapid Antigen Market Size by Region
4.1.1 Global Covid-19 Rapid Antigen Sales Quantity by Region (2018-2029)
4.1.2 Global Covid-19 Rapid Antigen Consumption Value by Region (2018-2029)
4.1.3 Global Covid-19 Rapid Antigen Average Price by Region (2018-2029)
4.2 North America Covid-19 Rapid Antigen Consumption Value (2018-2029)
4.3 Europe Covid-19 Rapid Antigen Consumption Value (2018-2029)
4.4 Asia-Pacific Covid-19 Rapid Antigen Consumption Value (2018-2029)
4.5 South America Covid-19 Rapid Antigen Consumption Value (2018-2029)
4.6 Middle East and Africa Covid-19 Rapid Antigen Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Covid-19 Rapid Antigen Sales Quantity by Type (2018-2029)
5.2 Global Covid-19 Rapid Antigen Consumption Value by Type (2018-2029)
5.3 Global Covid-19 Rapid Antigen Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Covid-19 Rapid Antigen Sales Quantity by Application (2018-2029)
6.2 Global Covid-19 Rapid Antigen Consumption Value by Application (2018-2029)
6.3 Global Covid-19 Rapid Antigen Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Covid-19 Rapid Antigen Sales Quantity by Type (2018-2029)
7.2 North America Covid-19 Rapid Antigen Sales Quantity by Application (2018-2029)
7.3 North America Covid-19 Rapid Antigen Market Size by Country
7.3.1 North America Covid-19 Rapid Antigen Sales Quantity by Country (2018-2029)
7.3.2 North America Covid-19 Rapid Antigen Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Covid-19 Rapid Antigen Sales Quantity by Type (2018-2029)
8.2 Europe Covid-19 Rapid Antigen Sales Quantity by Application (2018-2029)
8.3 Europe Covid-19 Rapid Antigen Market Size by Country
8.3.1 Europe Covid-19 Rapid Antigen Sales Quantity by Country (2018-2029)
8.3.2 Europe Covid-19 Rapid Antigen Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Covid-19 Rapid Antigen Market Size by Region
9.3.1 Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Covid-19 Rapid Antigen Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Covid-19 Rapid Antigen Sales Quantity by Type (2018-2029)
10.2 South America Covid-19 Rapid Antigen Sales Quantity by Application (2018-2029)
10.3 South America Covid-19 Rapid Antigen Market Size by Country
10.3.1 South America Covid-19 Rapid Antigen Sales Quantity by Country (2018-2029)
10.3.2 South America Covid-19 Rapid Antigen Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Covid-19 Rapid Antigen Market Size by Country
11.3.1 Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Covid-19 Rapid Antigen Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Covid-19 Rapid Antigen Market Drivers
12.2 Covid-19 Rapid Antigen Market Restraints
12.3 Covid-19 Rapid Antigen Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Covid-19 Rapid Antigen and Key Manufacturers
13.2 Manufacturing Costs Percentage of Covid-19 Rapid Antigen
13.3 Covid-19 Rapid Antigen Production Process
13.4 Covid-19 Rapid Antigen Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Covid-19 Rapid Antigen Typical Distributors
14.3 Covid-19 Rapid Antigen Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Covid-19 Rapid Antigen
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Covid-19 Rapid Antigen Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Nasal Swab
1.3.3 Oral Fluid/Saliva
1.4 Market Analysis by Application
1.4.1 Overview: Global Covid-19 Rapid Antigen Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Scientific Research
1.5 Global Covid-19 Rapid Antigen Market Size & Forecast
1.5.1 Global Covid-19 Rapid Antigen Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Covid-19 Rapid Antigen Sales Quantity (2018-2029)
1.5.3 Global Covid-19 Rapid Antigen Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Covid-19 Rapid Antigen Product and Services
2.1.4 Abbott Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Recent Developments/Updates
2.2 Access Bio
2.2.1 Access Bio Details
2.2.2 Access Bio Major Business
2.2.3 Access Bio Covid-19 Rapid Antigen Product and Services
2.2.4 Access Bio Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Access Bio Recent Developments/Updates
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business
2.3.3 BD Covid-19 Rapid Antigen Product and Services
2.3.4 BD Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BD Recent Developments/Updates
2.4 Quidel
2.4.1 Quidel Details
2.4.2 Quidel Major Business
2.4.3 Quidel Covid-19 Rapid Antigen Product and Services
2.4.4 Quidel Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Quidel Recent Developments/Updates
2.5 Fujirebio
2.5.1 Fujirebio Details
2.5.2 Fujirebio Major Business
2.5.3 Fujirebio Covid-19 Rapid Antigen Product and Services
2.5.4 Fujirebio Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Fujirebio Recent Developments/Updates
2.6 Ellume
2.6.1 Ellume Details
2.6.2 Ellume Major Business
2.6.3 Ellume Covid-19 Rapid Antigen Product and Services
2.6.4 Ellume Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Ellume Recent Developments/Updates
2.7 OraSure Technologies
2.7.1 OraSure Technologies Details
2.7.2 OraSure Technologies Major Business
2.7.3 OraSure Technologies Covid-19 Rapid Antigen Product and Services
2.7.4 OraSure Technologies Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 OraSure Technologies Recent Developments/Updates
2.8 Clip Health
2.8.1 Clip Health Details
2.8.2 Clip Health Major Business
2.8.3 Clip Health Covid-19 Rapid Antigen Product and Services
2.8.4 Clip Health Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Clip Health Recent Developments/Updates
2.9 Celltrion Healthcare
2.9.1 Celltrion Healthcare Details
2.9.2 Celltrion Healthcare Major Business
2.9.3 Celltrion Healthcare Covid-19 Rapid Antigen Product and Services
2.9.4 Celltrion Healthcare Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Celltrion Healthcare Recent Developments/Updates
2.10 Salofa Oy
2.10.1 Salofa Oy Details
2.10.2 Salofa Oy Major Business
2.10.3 Salofa Oy Covid-19 Rapid Antigen Product and Services
2.10.4 Salofa Oy Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Salofa Oy Recent Developments/Updates
2.11 iHealth Labs
2.11.1 iHealth Labs Details
2.11.2 iHealth Labs Major Business
2.11.3 iHealth Labs Covid-19 Rapid Antigen Product and Services
2.11.4 iHealth Labs Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 iHealth Labs Recent Developments/Updates
2.12 Novegent
2.12.1 Novegent Details
2.12.2 Novegent Major Business
2.12.3 Novegent Covid-19 Rapid Antigen Product and Services
2.12.4 Novegent Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Novegent Recent Developments/Updates
2.13 Hangzhou Alltest Biotech
2.13.1 Hangzhou Alltest Biotech Details
2.13.2 Hangzhou Alltest Biotech Major Business
2.13.3 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product and Services
2.13.4 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hangzhou Alltest Biotech Recent Developments/Updates
2.14 Guangzhou Decheng Biotechnology
2.14.1 Guangzhou Decheng Biotechnology Details
2.14.2 Guangzhou Decheng Biotechnology Major Business
2.14.3 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product and Services
2.14.4 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Guangzhou Decheng Biotechnology Recent Developments/Updates
2.15 SD Biosensor
2.15.1 SD Biosensor Details
2.15.2 SD Biosensor Major Business
2.15.3 SD Biosensor Covid-19 Rapid Antigen Product and Services
2.15.4 SD Biosensor Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 SD Biosensor Recent Developments/Updates
2.16 MP Biomedical
2.16.1 MP Biomedical Details
2.16.2 MP Biomedical Major Business
2.16.3 MP Biomedical Covid-19 Rapid Antigen Product and Services
2.16.4 MP Biomedical Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 MP Biomedical Recent Developments/Updates
2.17 Jiangsu Well Biotech
2.17.1 Jiangsu Well Biotech Details
2.17.2 Jiangsu Well Biotech Major Business
2.17.3 Jiangsu Well Biotech Covid-19 Rapid Antigen Product and Services
2.17.4 Jiangsu Well Biotech Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Jiangsu Well Biotech Recent Developments/Updates
2.18 CTK Biotech
2.18.1 CTK Biotech Details
2.18.2 CTK Biotech Major Business
2.18.3 CTK Biotech Covid-19 Rapid Antigen Product and Services
2.18.4 CTK Biotech Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 CTK Biotech Recent Developments/Updates
2.19 Hangzhou Laihe Biotech
2.19.1 Hangzhou Laihe Biotech Details
2.19.2 Hangzhou Laihe Biotech Major Business
2.19.3 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product and Services
2.19.4 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Hangzhou Laihe Biotech Recent Developments/Updates
2.20 Innovation Scientific
2.20.1 Innovation Scientific Details
2.20.2 Innovation Scientific Major Business
2.20.3 Innovation Scientific Covid-19 Rapid Antigen Product and Services
2.20.4 Innovation Scientific Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Innovation Scientific Recent Developments/Updates
2.21 Biohit Healthcare
2.21.1 Biohit Healthcare Details
2.21.2 Biohit Healthcare Major Business
2.21.3 Biohit Healthcare Covid-19 Rapid Antigen Product and Services
2.21.4 Biohit Healthcare Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Biohit Healthcare Recent Developments/Updates
2.22 ACON Biotech
2.22.1 ACON Biotech Details
2.22.2 ACON Biotech Major Business
2.22.3 ACON Biotech Covid-19 Rapid Antigen Product and Services
2.22.4 ACON Biotech Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 ACON Biotech Recent Developments/Updates
2.23 Assure Tech
2.23.1 Assure Tech Details
2.23.2 Assure Tech Major Business
2.23.3 Assure Tech Covid-19 Rapid Antigen Product and Services
2.23.4 Assure Tech Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Assure Tech Recent Developments/Updates
2.24 Hangzhou Clongene Biotech
2.24.1 Hangzhou Clongene Biotech Details
2.24.2 Hangzhou Clongene Biotech Major Business
2.24.3 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product and Services
2.24.4 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 Hangzhou Clongene Biotech Recent Developments/Updates
2.25 Hangzhou Testsea Biotechnology
2.25.1 Hangzhou Testsea Biotechnology Details
2.25.2 Hangzhou Testsea Biotechnology Major Business
2.25.3 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product and Services
2.25.4 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Hangzhou Testsea Biotechnology Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: COVID-19 RAPID ANTIGEN BY MANUFACTURER
3.1 Global Covid-19 Rapid Antigen Sales Quantity by Manufacturer (2018-2023)
3.2 Global Covid-19 Rapid Antigen Revenue by Manufacturer (2018-2023)
3.3 Global Covid-19 Rapid Antigen Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Covid-19 Rapid Antigen by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Covid-19 Rapid Antigen Manufacturer Market Share in 2022
3.4.2 Top 6 Covid-19 Rapid Antigen Manufacturer Market Share in 2022
3.5 Covid-19 Rapid Antigen Market: Overall Company Footprint Analysis
3.5.1 Covid-19 Rapid Antigen Market: Region Footprint
3.5.2 Covid-19 Rapid Antigen Market: Company Product Type Footprint
3.5.3 Covid-19 Rapid Antigen Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Covid-19 Rapid Antigen Market Size by Region
4.1.1 Global Covid-19 Rapid Antigen Sales Quantity by Region (2018-2029)
4.1.2 Global Covid-19 Rapid Antigen Consumption Value by Region (2018-2029)
4.1.3 Global Covid-19 Rapid Antigen Average Price by Region (2018-2029)
4.2 North America Covid-19 Rapid Antigen Consumption Value (2018-2029)
4.3 Europe Covid-19 Rapid Antigen Consumption Value (2018-2029)
4.4 Asia-Pacific Covid-19 Rapid Antigen Consumption Value (2018-2029)
4.5 South America Covid-19 Rapid Antigen Consumption Value (2018-2029)
4.6 Middle East and Africa Covid-19 Rapid Antigen Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Covid-19 Rapid Antigen Sales Quantity by Type (2018-2029)
5.2 Global Covid-19 Rapid Antigen Consumption Value by Type (2018-2029)
5.3 Global Covid-19 Rapid Antigen Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Covid-19 Rapid Antigen Sales Quantity by Application (2018-2029)
6.2 Global Covid-19 Rapid Antigen Consumption Value by Application (2018-2029)
6.3 Global Covid-19 Rapid Antigen Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Covid-19 Rapid Antigen Sales Quantity by Type (2018-2029)
7.2 North America Covid-19 Rapid Antigen Sales Quantity by Application (2018-2029)
7.3 North America Covid-19 Rapid Antigen Market Size by Country
7.3.1 North America Covid-19 Rapid Antigen Sales Quantity by Country (2018-2029)
7.3.2 North America Covid-19 Rapid Antigen Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Covid-19 Rapid Antigen Sales Quantity by Type (2018-2029)
8.2 Europe Covid-19 Rapid Antigen Sales Quantity by Application (2018-2029)
8.3 Europe Covid-19 Rapid Antigen Market Size by Country
8.3.1 Europe Covid-19 Rapid Antigen Sales Quantity by Country (2018-2029)
8.3.2 Europe Covid-19 Rapid Antigen Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Covid-19 Rapid Antigen Market Size by Region
9.3.1 Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Covid-19 Rapid Antigen Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Covid-19 Rapid Antigen Sales Quantity by Type (2018-2029)
10.2 South America Covid-19 Rapid Antigen Sales Quantity by Application (2018-2029)
10.3 South America Covid-19 Rapid Antigen Market Size by Country
10.3.1 South America Covid-19 Rapid Antigen Sales Quantity by Country (2018-2029)
10.3.2 South America Covid-19 Rapid Antigen Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Covid-19 Rapid Antigen Market Size by Country
11.3.1 Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Covid-19 Rapid Antigen Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Covid-19 Rapid Antigen Market Drivers
12.2 Covid-19 Rapid Antigen Market Restraints
12.3 Covid-19 Rapid Antigen Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Covid-19 Rapid Antigen and Key Manufacturers
13.2 Manufacturing Costs Percentage of Covid-19 Rapid Antigen
13.3 Covid-19 Rapid Antigen Production Process
13.4 Covid-19 Rapid Antigen Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Covid-19 Rapid Antigen Typical Distributors
14.3 Covid-19 Rapid Antigen Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Covid-19 Rapid Antigen Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Covid-19 Rapid Antigen Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Covid-19 Rapid Antigen Product and Services
Table 6. Abbott Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Abbott Recent Developments/Updates
Table 8. Access Bio Basic Information, Manufacturing Base and Competitors
Table 9. Access Bio Major Business
Table 10. Access Bio Covid-19 Rapid Antigen Product and Services
Table 11. Access Bio Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Access Bio Recent Developments/Updates
Table 13. BD Basic Information, Manufacturing Base and Competitors
Table 14. BD Major Business
Table 15. BD Covid-19 Rapid Antigen Product and Services
Table 16. BD Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BD Recent Developments/Updates
Table 18. Quidel Basic Information, Manufacturing Base and Competitors
Table 19. Quidel Major Business
Table 20. Quidel Covid-19 Rapid Antigen Product and Services
Table 21. Quidel Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Quidel Recent Developments/Updates
Table 23. Fujirebio Basic Information, Manufacturing Base and Competitors
Table 24. Fujirebio Major Business
Table 25. Fujirebio Covid-19 Rapid Antigen Product and Services
Table 26. Fujirebio Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Fujirebio Recent Developments/Updates
Table 28. Ellume Basic Information, Manufacturing Base and Competitors
Table 29. Ellume Major Business
Table 30. Ellume Covid-19 Rapid Antigen Product and Services
Table 31. Ellume Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Ellume Recent Developments/Updates
Table 33. OraSure Technologies Basic Information, Manufacturing Base and Competitors
Table 34. OraSure Technologies Major Business
Table 35. OraSure Technologies Covid-19 Rapid Antigen Product and Services
Table 36. OraSure Technologies Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. OraSure Technologies Recent Developments/Updates
Table 38. Clip Health Basic Information, Manufacturing Base and Competitors
Table 39. Clip Health Major Business
Table 40. Clip Health Covid-19 Rapid Antigen Product and Services
Table 41. Clip Health Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Clip Health Recent Developments/Updates
Table 43. Celltrion Healthcare Basic Information, Manufacturing Base and Competitors
Table 44. Celltrion Healthcare Major Business
Table 45. Celltrion Healthcare Covid-19 Rapid Antigen Product and Services
Table 46. Celltrion Healthcare Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Celltrion Healthcare Recent Developments/Updates
Table 48. Salofa Oy Basic Information, Manufacturing Base and Competitors
Table 49. Salofa Oy Major Business
Table 50. Salofa Oy Covid-19 Rapid Antigen Product and Services
Table 51. Salofa Oy Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Salofa Oy Recent Developments/Updates
Table 53. iHealth Labs Basic Information, Manufacturing Base and Competitors
Table 54. iHealth Labs Major Business
Table 55. iHealth Labs Covid-19 Rapid Antigen Product and Services
Table 56. iHealth Labs Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. iHealth Labs Recent Developments/Updates
Table 58. Novegent Basic Information, Manufacturing Base and Competitors
Table 59. Novegent Major Business
Table 60. Novegent Covid-19 Rapid Antigen Product and Services
Table 61. Novegent Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Novegent Recent Developments/Updates
Table 63. Hangzhou Alltest Biotech Basic Information, Manufacturing Base and Competitors
Table 64. Hangzhou Alltest Biotech Major Business
Table 65. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product and Services
Table 66. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Hangzhou Alltest Biotech Recent Developments/Updates
Table 68. Guangzhou Decheng Biotechnology Basic Information, Manufacturing Base and Competitors
Table 69. Guangzhou Decheng Biotechnology Major Business
Table 70. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product and Services
Table 71. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Guangzhou Decheng Biotechnology Recent Developments/Updates
Table 73. SD Biosensor Basic Information, Manufacturing Base and Competitors
Table 74. SD Biosensor Major Business
Table 75. SD Biosensor Covid-19 Rapid Antigen Product and Services
Table 76. SD Biosensor Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. SD Biosensor Recent Developments/Updates
Table 78. MP Biomedical Basic Information, Manufacturing Base and Competitors
Table 79. MP Biomedical Major Business
Table 80. MP Biomedical Covid-19 Rapid Antigen Product and Services
Table 81. MP Biomedical Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. MP Biomedical Recent Developments/Updates
Table 83. Jiangsu Well Biotech Basic Information, Manufacturing Base and Competitors
Table 84. Jiangsu Well Biotech Major Business
Table 85. Jiangsu Well Biotech Covid-19 Rapid Antigen Product and Services
Table 86. Jiangsu Well Biotech Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Jiangsu Well Biotech Recent Developments/Updates
Table 88. CTK Biotech Basic Information, Manufacturing Base and Competitors
Table 89. CTK Biotech Major Business
Table 90. CTK Biotech Covid-19 Rapid Antigen Product and Services
Table 91. CTK Biotech Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. CTK Biotech Recent Developments/Updates
Table 93. Hangzhou Laihe Biotech Basic Information, Manufacturing Base and Competitors
Table 94. Hangzhou Laihe Biotech Major Business
Table 95. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product and Services
Table 96. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Hangzhou Laihe Biotech Recent Developments/Updates
Table 98. Innovation Scientific Basic Information, Manufacturing Base and Competitors
Table 99. Innovation Scientific Major Business
Table 100. Innovation Scientific Covid-19 Rapid Antigen Product and Services
Table 101. Innovation Scientific Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Innovation Scientific Recent Developments/Updates
Table 103. Biohit Healthcare Basic Information, Manufacturing Base and Competitors
Table 104. Biohit Healthcare Major Business
Table 105. Biohit Healthcare Covid-19 Rapid Antigen Product and Services
Table 106. Biohit Healthcare Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Biohit Healthcare Recent Developments/Updates
Table 108. ACON Biotech Basic Information, Manufacturing Base and Competitors
Table 109. ACON Biotech Major Business
Table 110. ACON Biotech Covid-19 Rapid Antigen Product and Services
Table 111. ACON Biotech Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. ACON Biotech Recent Developments/Updates
Table 113. Assure Tech Basic Information, Manufacturing Base and Competitors
Table 114. Assure Tech Major Business
Table 115. Assure Tech Covid-19 Rapid Antigen Product and Services
Table 116. Assure Tech Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 117. Assure Tech Recent Developments/Updates
Table 118. Hangzhou Clongene Biotech Basic Information, Manufacturing Base and Competitors
Table 119. Hangzhou Clongene Biotech Major Business
Table 120. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product and Services
Table 121. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 122. Hangzhou Clongene Biotech Recent Developments/Updates
Table 123. Hangzhou Testsea Biotechnology Basic Information, Manufacturing Base and Competitors
Table 124. Hangzhou Testsea Biotechnology Major Business
Table 125. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product and Services
Table 126. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 127. Hangzhou Testsea Biotechnology Recent Developments/Updates
Table 128. Global Covid-19 Rapid Antigen Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 129. Global Covid-19 Rapid Antigen Revenue by Manufacturer (2018-2023) & (USD Million)
Table 130. Global Covid-19 Rapid Antigen Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 131. Market Position of Manufacturers in Covid-19 Rapid Antigen, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 132. Head Office and Covid-19 Rapid Antigen Production Site of Key Manufacturer
Table 133. Covid-19 Rapid Antigen Market: Company Product Type Footprint
Table 134. Covid-19 Rapid Antigen Market: Company Product Application Footprint
Table 135. Covid-19 Rapid Antigen New Market Entrants and Barriers to Market Entry
Table 136. Covid-19 Rapid Antigen Mergers, Acquisition, Agreements, and Collaborations
Table 137. Global Covid-19 Rapid Antigen Sales Quantity by Region (2018-2023) & (K Units)
Table 138. Global Covid-19 Rapid Antigen Sales Quantity by Region (2024-2029) & (K Units)
Table 139. Global Covid-19 Rapid Antigen Consumption Value by Region (2018-2023) & (USD Million)
Table 140. Global Covid-19 Rapid Antigen Consumption Value by Region (2024-2029) & (USD Million)
Table 141. Global Covid-19 Rapid Antigen Average Price by Region (2018-2023) & (US$/Unit)
Table 142. Global Covid-19 Rapid Antigen Average Price by Region (2024-2029) & (US$/Unit)
Table 143. Global Covid-19 Rapid Antigen Sales Quantity by Type (2018-2023) & (K Units)
Table 144. Global Covid-19 Rapid Antigen Sales Quantity by Type (2024-2029) & (K Units)
Table 145. Global Covid-19 Rapid Antigen Consumption Value by Type (2018-2023) & (USD Million)
Table 146. Global Covid-19 Rapid Antigen Consumption Value by Type (2024-2029) & (USD Million)
Table 147. Global Covid-19 Rapid Antigen Average Price by Type (2018-2023) & (US$/Unit)
Table 148. Global Covid-19 Rapid Antigen Average Price by Type (2024-2029) & (US$/Unit)
Table 149. Global Covid-19 Rapid Antigen Sales Quantity by Application (2018-2023) & (K Units)
Table 150. Global Covid-19 Rapid Antigen Sales Quantity by Application (2024-2029) & (K Units)
Table 151. Global Covid-19 Rapid Antigen Consumption Value by Application (2018-2023) & (USD Million)
Table 152. Global Covid-19 Rapid Antigen Consumption Value by Application (2024-2029) & (USD Million)
Table 153. Global Covid-19 Rapid Antigen Average Price by Application (2018-2023) & (US$/Unit)
Table 154. Global Covid-19 Rapid Antigen Average Price by Application (2024-2029) & (US$/Unit)
Table 155. North America Covid-19 Rapid Antigen Sales Quantity by Type (2018-2023) & (K Units)
Table 156. North America Covid-19 Rapid Antigen Sales Quantity by Type (2024-2029) & (K Units)
Table 157. North America Covid-19 Rapid Antigen Sales Quantity by Application (2018-2023) & (K Units)
Table 158. North America Covid-19 Rapid Antigen Sales Quantity by Application (2024-2029) & (K Units)
Table 159. North America Covid-19 Rapid Antigen Sales Quantity by Country (2018-2023) & (K Units)
Table 160. North America Covid-19 Rapid Antigen Sales Quantity by Country (2024-2029) & (K Units)
Table 161. North America Covid-19 Rapid Antigen Consumption Value by Country (2018-2023) & (USD Million)
Table 162. North America Covid-19 Rapid Antigen Consumption Value by Country (2024-2029) & (USD Million)
Table 163. Europe Covid-19 Rapid Antigen Sales Quantity by Type (2018-2023) & (K Units)
Table 164. Europe Covid-19 Rapid Antigen Sales Quantity by Type (2024-2029) & (K Units)
Table 165. Europe Covid-19 Rapid Antigen Sales Quantity by Application (2018-2023) & (K Units)
Table 166. Europe Covid-19 Rapid Antigen Sales Quantity by Application (2024-2029) & (K Units)
Table 167. Europe Covid-19 Rapid Antigen Sales Quantity by Country (2018-2023) & (K Units)
Table 168. Europe Covid-19 Rapid Antigen Sales Quantity by Country (2024-2029) & (K Units)
Table 169. Europe Covid-19 Rapid Antigen Consumption Value by Country (2018-2023) & (USD Million)
Table 170. Europe Covid-19 Rapid Antigen Consumption Value by Country (2024-2029) & (USD Million)
Table 171. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Type (2018-2023) & (K Units)
Table 172. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Type (2024-2029) & (K Units)
Table 173. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Application (2018-2023) & (K Units)
Table 174. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Application (2024-2029) & (K Units)
Table 175. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Region (2018-2023) & (K Units)
Table 176. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Region (2024-2029) & (K Units)
Table 177. Asia-Pacific Covid-19 Rapid Antigen Consumption Value by Region (2018-2023) & (USD Million)
Table 178. Asia-Pacific Covid-19 Rapid Antigen Consumption Value by Region (2024-2029) & (USD Million)
Table 179. South America Covid-19 Rapid Antigen Sales Quantity by Type (2018-2023) & (K Units)
Table 180. South America Covid-19 Rapid Antigen Sales Quantity by Type (2024-2029) & (K Units)
Table 181. South America Covid-19 Rapid Antigen Sales Quantity by Application (2018-2023) & (K Units)
Table 182. South America Covid-19 Rapid Antigen Sales Quantity by Application (2024-2029) & (K Units)
Table 183. South America Covid-19 Rapid Antigen Sales Quantity by Country (2018-2023) & (K Units)
Table 184. South America Covid-19 Rapid Antigen Sales Quantity by Country (2024-2029) & (K Units)
Table 185. South America Covid-19 Rapid Antigen Consumption Value by Country (2018-2023) & (USD Million)
Table 186. South America Covid-19 Rapid Antigen Consumption Value by Country (2024-2029) & (USD Million)
Table 187. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Type (2018-2023) & (K Units)
Table 188. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Type (2024-2029) & (K Units)
Table 189. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Application (2018-2023) & (K Units)
Table 190. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Application (2024-2029) & (K Units)
Table 191. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Region (2018-2023) & (K Units)
Table 192. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Region (2024-2029) & (K Units)
Table 193. Middle East & Africa Covid-19 Rapid Antigen Consumption Value by Region (2018-2023) & (USD Million)
Table 194. Middle East & Africa Covid-19 Rapid Antigen Consumption Value by Region (2024-2029) & (USD Million)
Table 195. Covid-19 Rapid Antigen Raw Material
Table 196. Key Manufacturers of Covid-19 Rapid Antigen Raw Materials
Table 197. Covid-19 Rapid Antigen Typical Distributors
Table 198. Covid-19 Rapid Antigen Typical Customers
Table 1. Global Covid-19 Rapid Antigen Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Covid-19 Rapid Antigen Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Covid-19 Rapid Antigen Product and Services
Table 6. Abbott Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Abbott Recent Developments/Updates
Table 8. Access Bio Basic Information, Manufacturing Base and Competitors
Table 9. Access Bio Major Business
Table 10. Access Bio Covid-19 Rapid Antigen Product and Services
Table 11. Access Bio Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Access Bio Recent Developments/Updates
Table 13. BD Basic Information, Manufacturing Base and Competitors
Table 14. BD Major Business
Table 15. BD Covid-19 Rapid Antigen Product and Services
Table 16. BD Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BD Recent Developments/Updates
Table 18. Quidel Basic Information, Manufacturing Base and Competitors
Table 19. Quidel Major Business
Table 20. Quidel Covid-19 Rapid Antigen Product and Services
Table 21. Quidel Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Quidel Recent Developments/Updates
Table 23. Fujirebio Basic Information, Manufacturing Base and Competitors
Table 24. Fujirebio Major Business
Table 25. Fujirebio Covid-19 Rapid Antigen Product and Services
Table 26. Fujirebio Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Fujirebio Recent Developments/Updates
Table 28. Ellume Basic Information, Manufacturing Base and Competitors
Table 29. Ellume Major Business
Table 30. Ellume Covid-19 Rapid Antigen Product and Services
Table 31. Ellume Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Ellume Recent Developments/Updates
Table 33. OraSure Technologies Basic Information, Manufacturing Base and Competitors
Table 34. OraSure Technologies Major Business
Table 35. OraSure Technologies Covid-19 Rapid Antigen Product and Services
Table 36. OraSure Technologies Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. OraSure Technologies Recent Developments/Updates
Table 38. Clip Health Basic Information, Manufacturing Base and Competitors
Table 39. Clip Health Major Business
Table 40. Clip Health Covid-19 Rapid Antigen Product and Services
Table 41. Clip Health Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Clip Health Recent Developments/Updates
Table 43. Celltrion Healthcare Basic Information, Manufacturing Base and Competitors
Table 44. Celltrion Healthcare Major Business
Table 45. Celltrion Healthcare Covid-19 Rapid Antigen Product and Services
Table 46. Celltrion Healthcare Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Celltrion Healthcare Recent Developments/Updates
Table 48. Salofa Oy Basic Information, Manufacturing Base and Competitors
Table 49. Salofa Oy Major Business
Table 50. Salofa Oy Covid-19 Rapid Antigen Product and Services
Table 51. Salofa Oy Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Salofa Oy Recent Developments/Updates
Table 53. iHealth Labs Basic Information, Manufacturing Base and Competitors
Table 54. iHealth Labs Major Business
Table 55. iHealth Labs Covid-19 Rapid Antigen Product and Services
Table 56. iHealth Labs Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. iHealth Labs Recent Developments/Updates
Table 58. Novegent Basic Information, Manufacturing Base and Competitors
Table 59. Novegent Major Business
Table 60. Novegent Covid-19 Rapid Antigen Product and Services
Table 61. Novegent Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Novegent Recent Developments/Updates
Table 63. Hangzhou Alltest Biotech Basic Information, Manufacturing Base and Competitors
Table 64. Hangzhou Alltest Biotech Major Business
Table 65. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product and Services
Table 66. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Hangzhou Alltest Biotech Recent Developments/Updates
Table 68. Guangzhou Decheng Biotechnology Basic Information, Manufacturing Base and Competitors
Table 69. Guangzhou Decheng Biotechnology Major Business
Table 70. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product and Services
Table 71. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Guangzhou Decheng Biotechnology Recent Developments/Updates
Table 73. SD Biosensor Basic Information, Manufacturing Base and Competitors
Table 74. SD Biosensor Major Business
Table 75. SD Biosensor Covid-19 Rapid Antigen Product and Services
Table 76. SD Biosensor Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. SD Biosensor Recent Developments/Updates
Table 78. MP Biomedical Basic Information, Manufacturing Base and Competitors
Table 79. MP Biomedical Major Business
Table 80. MP Biomedical Covid-19 Rapid Antigen Product and Services
Table 81. MP Biomedical Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. MP Biomedical Recent Developments/Updates
Table 83. Jiangsu Well Biotech Basic Information, Manufacturing Base and Competitors
Table 84. Jiangsu Well Biotech Major Business
Table 85. Jiangsu Well Biotech Covid-19 Rapid Antigen Product and Services
Table 86. Jiangsu Well Biotech Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Jiangsu Well Biotech Recent Developments/Updates
Table 88. CTK Biotech Basic Information, Manufacturing Base and Competitors
Table 89. CTK Biotech Major Business
Table 90. CTK Biotech Covid-19 Rapid Antigen Product and Services
Table 91. CTK Biotech Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. CTK Biotech Recent Developments/Updates
Table 93. Hangzhou Laihe Biotech Basic Information, Manufacturing Base and Competitors
Table 94. Hangzhou Laihe Biotech Major Business
Table 95. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product and Services
Table 96. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Hangzhou Laihe Biotech Recent Developments/Updates
Table 98. Innovation Scientific Basic Information, Manufacturing Base and Competitors
Table 99. Innovation Scientific Major Business
Table 100. Innovation Scientific Covid-19 Rapid Antigen Product and Services
Table 101. Innovation Scientific Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Innovation Scientific Recent Developments/Updates
Table 103. Biohit Healthcare Basic Information, Manufacturing Base and Competitors
Table 104. Biohit Healthcare Major Business
Table 105. Biohit Healthcare Covid-19 Rapid Antigen Product and Services
Table 106. Biohit Healthcare Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Biohit Healthcare Recent Developments/Updates
Table 108. ACON Biotech Basic Information, Manufacturing Base and Competitors
Table 109. ACON Biotech Major Business
Table 110. ACON Biotech Covid-19 Rapid Antigen Product and Services
Table 111. ACON Biotech Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. ACON Biotech Recent Developments/Updates
Table 113. Assure Tech Basic Information, Manufacturing Base and Competitors
Table 114. Assure Tech Major Business
Table 115. Assure Tech Covid-19 Rapid Antigen Product and Services
Table 116. Assure Tech Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 117. Assure Tech Recent Developments/Updates
Table 118. Hangzhou Clongene Biotech Basic Information, Manufacturing Base and Competitors
Table 119. Hangzhou Clongene Biotech Major Business
Table 120. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product and Services
Table 121. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 122. Hangzhou Clongene Biotech Recent Developments/Updates
Table 123. Hangzhou Testsea Biotechnology Basic Information, Manufacturing Base and Competitors
Table 124. Hangzhou Testsea Biotechnology Major Business
Table 125. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product and Services
Table 126. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 127. Hangzhou Testsea Biotechnology Recent Developments/Updates
Table 128. Global Covid-19 Rapid Antigen Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 129. Global Covid-19 Rapid Antigen Revenue by Manufacturer (2018-2023) & (USD Million)
Table 130. Global Covid-19 Rapid Antigen Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 131. Market Position of Manufacturers in Covid-19 Rapid Antigen, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 132. Head Office and Covid-19 Rapid Antigen Production Site of Key Manufacturer
Table 133. Covid-19 Rapid Antigen Market: Company Product Type Footprint
Table 134. Covid-19 Rapid Antigen Market: Company Product Application Footprint
Table 135. Covid-19 Rapid Antigen New Market Entrants and Barriers to Market Entry
Table 136. Covid-19 Rapid Antigen Mergers, Acquisition, Agreements, and Collaborations
Table 137. Global Covid-19 Rapid Antigen Sales Quantity by Region (2018-2023) & (K Units)
Table 138. Global Covid-19 Rapid Antigen Sales Quantity by Region (2024-2029) & (K Units)
Table 139. Global Covid-19 Rapid Antigen Consumption Value by Region (2018-2023) & (USD Million)
Table 140. Global Covid-19 Rapid Antigen Consumption Value by Region (2024-2029) & (USD Million)
Table 141. Global Covid-19 Rapid Antigen Average Price by Region (2018-2023) & (US$/Unit)
Table 142. Global Covid-19 Rapid Antigen Average Price by Region (2024-2029) & (US$/Unit)
Table 143. Global Covid-19 Rapid Antigen Sales Quantity by Type (2018-2023) & (K Units)
Table 144. Global Covid-19 Rapid Antigen Sales Quantity by Type (2024-2029) & (K Units)
Table 145. Global Covid-19 Rapid Antigen Consumption Value by Type (2018-2023) & (USD Million)
Table 146. Global Covid-19 Rapid Antigen Consumption Value by Type (2024-2029) & (USD Million)
Table 147. Global Covid-19 Rapid Antigen Average Price by Type (2018-2023) & (US$/Unit)
Table 148. Global Covid-19 Rapid Antigen Average Price by Type (2024-2029) & (US$/Unit)
Table 149. Global Covid-19 Rapid Antigen Sales Quantity by Application (2018-2023) & (K Units)
Table 150. Global Covid-19 Rapid Antigen Sales Quantity by Application (2024-2029) & (K Units)
Table 151. Global Covid-19 Rapid Antigen Consumption Value by Application (2018-2023) & (USD Million)
Table 152. Global Covid-19 Rapid Antigen Consumption Value by Application (2024-2029) & (USD Million)
Table 153. Global Covid-19 Rapid Antigen Average Price by Application (2018-2023) & (US$/Unit)
Table 154. Global Covid-19 Rapid Antigen Average Price by Application (2024-2029) & (US$/Unit)
Table 155. North America Covid-19 Rapid Antigen Sales Quantity by Type (2018-2023) & (K Units)
Table 156. North America Covid-19 Rapid Antigen Sales Quantity by Type (2024-2029) & (K Units)
Table 157. North America Covid-19 Rapid Antigen Sales Quantity by Application (2018-2023) & (K Units)
Table 158. North America Covid-19 Rapid Antigen Sales Quantity by Application (2024-2029) & (K Units)
Table 159. North America Covid-19 Rapid Antigen Sales Quantity by Country (2018-2023) & (K Units)
Table 160. North America Covid-19 Rapid Antigen Sales Quantity by Country (2024-2029) & (K Units)
Table 161. North America Covid-19 Rapid Antigen Consumption Value by Country (2018-2023) & (USD Million)
Table 162. North America Covid-19 Rapid Antigen Consumption Value by Country (2024-2029) & (USD Million)
Table 163. Europe Covid-19 Rapid Antigen Sales Quantity by Type (2018-2023) & (K Units)
Table 164. Europe Covid-19 Rapid Antigen Sales Quantity by Type (2024-2029) & (K Units)
Table 165. Europe Covid-19 Rapid Antigen Sales Quantity by Application (2018-2023) & (K Units)
Table 166. Europe Covid-19 Rapid Antigen Sales Quantity by Application (2024-2029) & (K Units)
Table 167. Europe Covid-19 Rapid Antigen Sales Quantity by Country (2018-2023) & (K Units)
Table 168. Europe Covid-19 Rapid Antigen Sales Quantity by Country (2024-2029) & (K Units)
Table 169. Europe Covid-19 Rapid Antigen Consumption Value by Country (2018-2023) & (USD Million)
Table 170. Europe Covid-19 Rapid Antigen Consumption Value by Country (2024-2029) & (USD Million)
Table 171. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Type (2018-2023) & (K Units)
Table 172. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Type (2024-2029) & (K Units)
Table 173. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Application (2018-2023) & (K Units)
Table 174. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Application (2024-2029) & (K Units)
Table 175. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Region (2018-2023) & (K Units)
Table 176. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity by Region (2024-2029) & (K Units)
Table 177. Asia-Pacific Covid-19 Rapid Antigen Consumption Value by Region (2018-2023) & (USD Million)
Table 178. Asia-Pacific Covid-19 Rapid Antigen Consumption Value by Region (2024-2029) & (USD Million)
Table 179. South America Covid-19 Rapid Antigen Sales Quantity by Type (2018-2023) & (K Units)
Table 180. South America Covid-19 Rapid Antigen Sales Quantity by Type (2024-2029) & (K Units)
Table 181. South America Covid-19 Rapid Antigen Sales Quantity by Application (2018-2023) & (K Units)
Table 182. South America Covid-19 Rapid Antigen Sales Quantity by Application (2024-2029) & (K Units)
Table 183. South America Covid-19 Rapid Antigen Sales Quantity by Country (2018-2023) & (K Units)
Table 184. South America Covid-19 Rapid Antigen Sales Quantity by Country (2024-2029) & (K Units)
Table 185. South America Covid-19 Rapid Antigen Consumption Value by Country (2018-2023) & (USD Million)
Table 186. South America Covid-19 Rapid Antigen Consumption Value by Country (2024-2029) & (USD Million)
Table 187. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Type (2018-2023) & (K Units)
Table 188. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Type (2024-2029) & (K Units)
Table 189. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Application (2018-2023) & (K Units)
Table 190. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Application (2024-2029) & (K Units)
Table 191. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Region (2018-2023) & (K Units)
Table 192. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity by Region (2024-2029) & (K Units)
Table 193. Middle East & Africa Covid-19 Rapid Antigen Consumption Value by Region (2018-2023) & (USD Million)
Table 194. Middle East & Africa Covid-19 Rapid Antigen Consumption Value by Region (2024-2029) & (USD Million)
Table 195. Covid-19 Rapid Antigen Raw Material
Table 196. Key Manufacturers of Covid-19 Rapid Antigen Raw Materials
Table 197. Covid-19 Rapid Antigen Typical Distributors
Table 198. Covid-19 Rapid Antigen Typical Customers
LIST OF FIGURES
Figure 1. Covid-19 Rapid Antigen Picture
Figure 2. Global Covid-19 Rapid Antigen Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Covid-19 Rapid Antigen Consumption Value Market Share by Type in 2022
Figure 4. Nasal Swab Examples
Figure 5. Oral Fluid/Saliva Examples
Figure 6. Global Covid-19 Rapid Antigen Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Covid-19 Rapid Antigen Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Scientific Research Examples
Figure 10. Global Covid-19 Rapid Antigen Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Covid-19 Rapid Antigen Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Covid-19 Rapid Antigen Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Covid-19 Rapid Antigen Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Covid-19 Rapid Antigen Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Covid-19 Rapid Antigen Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Covid-19 Rapid Antigen by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Covid-19 Rapid Antigen Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Covid-19 Rapid Antigen Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Covid-19 Rapid Antigen Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Covid-19 Rapid Antigen Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Covid-19 Rapid Antigen Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Covid-19 Rapid Antigen Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Covid-19 Rapid Antigen Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Covid-19 Rapid Antigen Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Covid-19 Rapid Antigen Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Covid-19 Rapid Antigen Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Covid-19 Rapid Antigen Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Covid-19 Rapid Antigen Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Covid-19 Rapid Antigen Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Covid-19 Rapid Antigen Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Covid-19 Rapid Antigen Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Covid-19 Rapid Antigen Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Covid-19 Rapid Antigen Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Covid-19 Rapid Antigen Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Covid-19 Rapid Antigen Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Covid-19 Rapid Antigen Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Covid-19 Rapid Antigen Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Covid-19 Rapid Antigen Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Covid-19 Rapid Antigen Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Covid-19 Rapid Antigen Consumption Value Market Share by Region (2018-2029)
Figure 52. China Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Covid-19 Rapid Antigen Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Covid-19 Rapid Antigen Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Covid-19 Rapid Antigen Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Covid-19 Rapid Antigen Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Covid-19 Rapid Antigen Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Covid-19 Rapid Antigen Market Drivers
Figure 73. Covid-19 Rapid Antigen Market Restraints
Figure 74. Covid-19 Rapid Antigen Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Covid-19 Rapid Antigen in 2022
Figure 77. Manufacturing Process Analysis of Covid-19 Rapid Antigen
Figure 78. Covid-19 Rapid Antigen Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Covid-19 Rapid Antigen Picture
Figure 2. Global Covid-19 Rapid Antigen Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Covid-19 Rapid Antigen Consumption Value Market Share by Type in 2022
Figure 4. Nasal Swab Examples
Figure 5. Oral Fluid/Saliva Examples
Figure 6. Global Covid-19 Rapid Antigen Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Covid-19 Rapid Antigen Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Scientific Research Examples
Figure 10. Global Covid-19 Rapid Antigen Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Covid-19 Rapid Antigen Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Covid-19 Rapid Antigen Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Covid-19 Rapid Antigen Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Covid-19 Rapid Antigen Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Covid-19 Rapid Antigen Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Covid-19 Rapid Antigen by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Covid-19 Rapid Antigen Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Covid-19 Rapid Antigen Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Covid-19 Rapid Antigen Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Covid-19 Rapid Antigen Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Covid-19 Rapid Antigen Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Covid-19 Rapid Antigen Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Covid-19 Rapid Antigen Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Covid-19 Rapid Antigen Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Covid-19 Rapid Antigen Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Covid-19 Rapid Antigen Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Covid-19 Rapid Antigen Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Covid-19 Rapid Antigen Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Covid-19 Rapid Antigen Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Covid-19 Rapid Antigen Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Covid-19 Rapid Antigen Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Covid-19 Rapid Antigen Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Covid-19 Rapid Antigen Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Covid-19 Rapid Antigen Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Covid-19 Rapid Antigen Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Covid-19 Rapid Antigen Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Covid-19 Rapid Antigen Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Covid-19 Rapid Antigen Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Covid-19 Rapid Antigen Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Covid-19 Rapid Antigen Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Covid-19 Rapid Antigen Consumption Value Market Share by Region (2018-2029)
Figure 52. China Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Covid-19 Rapid Antigen Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Covid-19 Rapid Antigen Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Covid-19 Rapid Antigen Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Covid-19 Rapid Antigen Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Covid-19 Rapid Antigen Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Covid-19 Rapid Antigen Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Covid-19 Rapid Antigen Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Covid-19 Rapid Antigen Market Drivers
Figure 73. Covid-19 Rapid Antigen Market Restraints
Figure 74. Covid-19 Rapid Antigen Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Covid-19 Rapid Antigen in 2022
Figure 77. Manufacturing Process Analysis of Covid-19 Rapid Antigen
Figure 78. Covid-19 Rapid Antigen Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
